Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0915_j.immuni.2020.08.005

Blocking glucocorticoid signaling to increase checkpoint inhibitor sensitivity

Sep 29, 2020 | 12:53 AM GMT

DISEASE CATEGORY: Cancer

INDICATION: Melanoma; colorectal cancer

Inhibiting the glucocorticoid receptor could

Read the full 228 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE